Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA

Go back to Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA
Amgen Inc (NASDAQ: AMGN) Delayed: 401.75 -1.29 (0.32%)
Previous Close $403.04    52 Week High $176.85 
Open $399.03    52 Week Low $133.64 
Day High $403.50    P/E 60.50 
Day Low $397.03    EPS $6.64 
Volume 778,636       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 895,640